Michael S. Abrams, CFO of NRX Pharmaceuticals NRXP, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/02/07.

MA

MA

Michael S. Abrams

CFO

Company

NRX Pharmaceuticals NRXP

First filing

23/09/08

Trades

3 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/02/07

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AT Arch Therapeutics	Open-market buy	23/08/31	23/09/08	10,292 sh	$0.28	$2,881.76	No record